ACURX PHARMACEUTICALS INC
ACXP·00510M203·US·Common Stock·Healthcare - Biotechnology-13D/G
ACXP (ACURX PHARMACEUTICALS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: JANE STREET GROUP, LLC ($202,722), VANGUARD CAPITAL MANAGEMENT LLC ($115,377), GEODE CAPITAL MANAGEMENT, LLC ($92,080). Net institutional sentiment: Mixed.
12
Holders
$529,283
Total Value
60% (10)
Consensus
6 buying - 4 selling
13F: Insider & Congress:
Who's Trading
ActivistARArmistice Capital, LLC5.0%Nov 14, 2025
ActivistARArmistice Capital, LLC10.0%Aug 14, 2025
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer